Irritable Bowel Syndrome Trial, Recruiting NCT06647043 Sponsor: Universiti Sains Malaysia Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT06647043
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male or female, aged between 18 and 70 years old
  • You have been diagnosed with Irritable Bowel Syndrome (IBS) with diarrhoea or mixed bowel habits, based on having stomach pain or discomfort at least 3 days per month for the last 3 months, with symptoms starting at least 6 months ago, plus at least two of these: symptoms improve after going to the toilet, symptoms started when your bowel movements became more or less frequent, or symptoms started when your stool became harder or looser
  • Alternatively, you experience loose or watery stools (without pain) in at least 75% of your bowel movements for at least 3 months over the past 6 months (known as functional diarrhoea)
  • You have had a colonoscopy (a camera examination of the bowel) within the last 5 years with a normal result
  • You are able to read and fill in questionnaires
  • You are willing to give written consent to take part in the study

Who may not be able to join:

  • You have been diagnosed with conditions such as inflammatory bowel disease, lactose intolerance, coeliac disease, diabetes, thyroid problems, cancer, immune system disorders, autoimmune diseases, or severe liver or kidney problems
  • You have had surgery on your small or large intestine, or have had your appendix, womb, or gallbladder removed in the last 6 months
  • You have a severe mental illness, or your psychiatric medication type or dose has changed in the last 3 months (confirm with trial site)
  • You currently have an active infection
  • You have used prebiotics, probiotics, antibiotics, or anti-inflammatory drugs in the last 2 weeks
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yeong Yeh Lee, Universiti Sains Malaysia

Phone: +601161203432

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universiti Sains Malaysia
Registry
ClinicalTrials.gov
Start date
23 February 2025
Est. completion
30 June 2025

Where this trial is recruiting

🇲🇾 Malaysia

Primary endpoints

The improvement of IBS severity using IBS severity scoring system (IBS-SSS) at month 3 after taking SMT04 Pro.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov